Delivery Order SPE2DB22D3016-SPE2DB24FAVZ2

Award Date 5/17/24
Potential Completion Date 5/20/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,298.08 firm fixed-price delivery order is for the supply of 4,565,092,057 Celecoxib 200 mg capsules. The contract has a period of performance through July 10, 2024 and does not include a set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract award, valued at $25,773.44, is for the delivery of 4566367910 Celecoxib 200 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 1, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,248.98, is for the delivery of 4,567,886,446 units of the drug Celecoxib 200 mg capsules. The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,619.93 firm fixed price delivery order is for the supply of 100 milligram Celebrex capsules. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
This federal contract award is for the delivery of CELECOXIB 200 MG CAPSULE 500S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,016.10 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on November 30, 2021. The contract has an ultimate completion date of December 1, 2021 and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,716.28 delivery order is for the supply of Celecoxib 400 mg capsules, a pharmaceutical product. The contract has a firm fixed price and no set-aside requirement, indicating full and open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,748.42, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Celecoxib 200mg, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly...
This federal contract award with ID SPE2DX15D6028|B456 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $303,759.00 firm-fixed-price delivery order is for the medical supply Celecoxib 200mg, a pharmaceutical product. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award, identified as SPE2DX15D6028|K333, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $77,671.23 firm fixed-price delivery order is for the supply of 4536093010 - CELEBREX 100MG 500S, a medication. The contract has an ultimate completion date of December 7, 2016 and was awarded on November 8, 2016. This award is associated with a larger...
Defense Logistics Agency awarded a delivery order against an unspecified contract vehicle to Amerisourcebergen Drug Corp on October 18, 2023. The $293 firm fixed price order is for 500 capsules of the generic drug celecoxib 200 mg. Performance will occur at the contractor's facility located in Conshohocken, Pennsylvania, with an expected completion date of October 19, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, operating as the prime and only contractor....
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAVZ2
    Delivery Order

This federal contract award of $1,092.04 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Celecoxib 200 mg capsules. The contract is a delivery order with a firm fixed price, and has a completion date of May 20, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This particular contract award was not set aside for any specific business designation.

Generated 8/16/24, 10:15 AM